Healthcare is moving at a massive pace. We need technologies that bring clinicians, their patients and their information together for more efficient , better quality care. With progress in mobility, communications and information management the tipping point for "Virtual Medicine" has now arrived.
This presentation provides details on how The CareCycle Navigator can receive biometric data from devices such as blood pressure cuffs and wearable devices, like those provided by A&D Medical, and deliver it in such a manner as to allow for wellness and health care intervention.
Kenya e-Wallet: Connecting people to better healthcareHFG Project
Presented at “Financial Protection and Improved Access to Health Care: Peer-to-Peer Learning Workshop Finding Solutions to Common Challenges” in Accra, Ghana, February 2016. To learn more, visit: https://www.hfgproject.org/ghana-uhc-workshop
mHealth Israel_Back-casting: How Covid-19 Impacted Digital Health Investment,...Levi Shapiro
Back-Casting: How Covid-19 Impacted Digital Health Investment, 2020-2025. Presentation by Levi Shapiro, Founder, mHealth Israel, April 9, 2020. Review of 6 likely outcomes for digital health investment as a result of CoVID-19:
1) BioConvergance
2) Pharma (and Biotech) is KING
3) Remote Medicine Spikes
4) Decline of Direct to Consumer
5) Providers Step Back from the Venture Game
6) Hospital Supply Chain and IT Management
mHealth Israel_Selling into French Hospitals and Public Sector_Alcatel-Lucent...Levi Shapiro
Selling to French Hospitals- Presentation by Nicole Hill, Global Healthcare Sector Director, Alcatel-Lucent Enterprise, for mHealth Israel, April 2, 2020. Sections include:
- Overview of Healthcare at Alcatel-Lucent Enterprise
- Healthcare Transformation in France
- Addressing the French Market: Key segments
- How to sell into French Hospitals
This presentation provides details on how The CareCycle Navigator can receive biometric data from devices such as blood pressure cuffs and wearable devices, like those provided by A&D Medical, and deliver it in such a manner as to allow for wellness and health care intervention.
Kenya e-Wallet: Connecting people to better healthcareHFG Project
Presented at “Financial Protection and Improved Access to Health Care: Peer-to-Peer Learning Workshop Finding Solutions to Common Challenges” in Accra, Ghana, February 2016. To learn more, visit: https://www.hfgproject.org/ghana-uhc-workshop
mHealth Israel_Back-casting: How Covid-19 Impacted Digital Health Investment,...Levi Shapiro
Back-Casting: How Covid-19 Impacted Digital Health Investment, 2020-2025. Presentation by Levi Shapiro, Founder, mHealth Israel, April 9, 2020. Review of 6 likely outcomes for digital health investment as a result of CoVID-19:
1) BioConvergance
2) Pharma (and Biotech) is KING
3) Remote Medicine Spikes
4) Decline of Direct to Consumer
5) Providers Step Back from the Venture Game
6) Hospital Supply Chain and IT Management
mHealth Israel_Selling into French Hospitals and Public Sector_Alcatel-Lucent...Levi Shapiro
Selling to French Hospitals- Presentation by Nicole Hill, Global Healthcare Sector Director, Alcatel-Lucent Enterprise, for mHealth Israel, April 2, 2020. Sections include:
- Overview of Healthcare at Alcatel-Lucent Enterprise
- Healthcare Transformation in France
- Addressing the French Market: Key segments
- How to sell into French Hospitals
“In 2017, we can observe the Healthcare industry has become further advanced, by enabling communications across different channels and technologies.”
visit our page on linkedin page : http://bit.ly/2cgEm9x
Visit our website @: http://bit.ly/2dARnY8
(OR) Write us for free demo and estimation at: info@custom-soft.com
Machine learning is a type of artificial intelligence that is concentrated on developing algorithms that analyze data and predict future events with tremendous accuracy. It is a technology that is well suited to identify hidden trends and patterns in vast amounts of data, not visible to the human eye. Jonathan Vallée, CTO of AlayaCare, an end-to-end home healthcare software solution, discusses the importance of collecting and analyzing data, provide real examples of feasible tech solutions organizations could implement today, explore the insights gained from utilizing machine learning, and present the results of two studies on applying machine learning to streams of incoming remote patient monitoring vitals for decision support.
Digital health innovation - future nhs stage, 1pm, 2 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Presentation of the Integrated eDiagnostic Approach (IeDA - http://ieda-project.org) during the 9th European Congress on Tropical Medicine and International Health (ECTMIH 2015) in Basel, Switzerland.
IeDA is a strategy aiming at strengthening health systems with the use of mobile technology, the appropriate use of data and targeted supervisions.
Digital Health: Take Two Apps and Call Me in the MorningRobin Raskin
Presented on March 20 at the Hudson Valley Economic Development Forum on Digital Health
Presentation focuses on consumer available gadgets including: fitness and health monitors
HxRefactored 2015: Drew Schiller "Beyond the Bracelet"HxRefactored
Drew Schiller, Co-founder & CTO of Validic discusses changes in healthcare as a result of the wearable movement which enables patients to take a more active role in their own healthcare.
Patient Engagement: The Next Wave of Change in Healthcare ITCascadia Capital
Patient Engagement is one of the fastest growing sub verticals in Healthcare. Is it really going to solve some of the big issues plaguing the Healthcare system? We think so.
Key points in this year’s presentation include:
- Medtech market size and growth rate
- Demographic and economic trends reshaping OEM product lines for the next decades
- Redefinition of what constitutes a medical device
- The size and growth rate of the medical device supply chain
- Changing roles for the contract manufacturing incumbents?
- Strategies for participating in the digitization of devices and systems
As always, I am happy to present Global Trends to you or your firm. Please reach me at tfreeman@asfreeman.com with questions, comments, or requests.
“In 2017, we can observe the Healthcare industry has become further advanced, by enabling communications across different channels and technologies.”
visit our page on linkedin page : http://bit.ly/2cgEm9x
Visit our website @: http://bit.ly/2dARnY8
(OR) Write us for free demo and estimation at: info@custom-soft.com
Machine learning is a type of artificial intelligence that is concentrated on developing algorithms that analyze data and predict future events with tremendous accuracy. It is a technology that is well suited to identify hidden trends and patterns in vast amounts of data, not visible to the human eye. Jonathan Vallée, CTO of AlayaCare, an end-to-end home healthcare software solution, discusses the importance of collecting and analyzing data, provide real examples of feasible tech solutions organizations could implement today, explore the insights gained from utilizing machine learning, and present the results of two studies on applying machine learning to streams of incoming remote patient monitoring vitals for decision support.
Digital health innovation - future nhs stage, 1pm, 2 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Presentation of the Integrated eDiagnostic Approach (IeDA - http://ieda-project.org) during the 9th European Congress on Tropical Medicine and International Health (ECTMIH 2015) in Basel, Switzerland.
IeDA is a strategy aiming at strengthening health systems with the use of mobile technology, the appropriate use of data and targeted supervisions.
Digital Health: Take Two Apps and Call Me in the MorningRobin Raskin
Presented on March 20 at the Hudson Valley Economic Development Forum on Digital Health
Presentation focuses on consumer available gadgets including: fitness and health monitors
HxRefactored 2015: Drew Schiller "Beyond the Bracelet"HxRefactored
Drew Schiller, Co-founder & CTO of Validic discusses changes in healthcare as a result of the wearable movement which enables patients to take a more active role in their own healthcare.
Patient Engagement: The Next Wave of Change in Healthcare ITCascadia Capital
Patient Engagement is one of the fastest growing sub verticals in Healthcare. Is it really going to solve some of the big issues plaguing the Healthcare system? We think so.
Key points in this year’s presentation include:
- Medtech market size and growth rate
- Demographic and economic trends reshaping OEM product lines for the next decades
- Redefinition of what constitutes a medical device
- The size and growth rate of the medical device supply chain
- Changing roles for the contract manufacturing incumbents?
- Strategies for participating in the digitization of devices and systems
As always, I am happy to present Global Trends to you or your firm. Please reach me at tfreeman@asfreeman.com with questions, comments, or requests.
By: Karsten Russell-Wood, Philips Hospital to Home
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
Webinar: Digital Health Strategy: Leveraging Emerging Technologies in HealthcareIntellectsoft
WEBINAR VIDEO - https://www.intellectsoft.net/l/31/webinar-digital-healthcare
JOIN OUR WEBINAR TO:
- Explore what changed for healthcare practices and operations during COVID-19 and predict what leaders can expect in terms of recovery;
- Discover today’s featured examples of our clients’ technology solutions that can help you provide better and more efficient services;
- Discuss how to evolve and adapt for the rest of 2020 and into 2021 using emerging technologies and more efficient solutions.
BEST FOR:
- Сhief Medical Officers
- Doctors Pharmaceuticals
- HR Department Outstaffing
- Telemedicine Workers
- Insurance Companies
- Pharmacies
- Laboratories
- Private Hospitals
- Academical Health Centres
- Private Healthcare Facilities
- Management Information Systems
https://www.intellectsoft.net/
2016 IBM Interconnect - medical devices transformationElizabeth Koumpan
Emerging technologies such as Internet of Things, 3D Printing are driving the creation of new business models and forcing the Industry for transformation. The product centric model where the Industry main objective was to develop the device, is moving to software and services model, with the focus on Big Data & Analytics, Integration and Cloud.
The maturation of technologies such as social, mobile, analytics, cloud, 3D printing, bio- and nanotechnology are rapidly shifting the competitive landscape. These emerging technologies create an environment that is connected and open, simple and intelligent, fast and scalable. Organizations must embrace disruptive technologies to drive innovation
With the onslaught of the Covid-19 pandemic, demand for Telehealth accelerated overnight. A 2020 case study by Accenture cites a 1000% increase in demand with a US based national Telehealth leader that was covering 80 million people, 2,000 hospitals, 55 health plan providers and 62,000 doctors post the pandemic. From pre-Covid 19 annual revenue of $3 billion, the US Telehealth has the potential to exceed $250 billion by 2025.
Healthcare On Demand: New Provider Business Models for the Digital EconomyCognizant
Health consumers empowered by digital technology now expect on-demand, anytime, anywhere service, forcing providers to develop new models of care to compete successfully in the emerging consumer-to-business health marketplace.
'The Digital Healthcare Leap' highlights insights into how digital health could be an answer to the emerging markets’ challenge to achieve sustainable growth; and leapfrog the developed nations to provide quality, affordable, universal and patient-centric care.
With increased internet and smartphone penetration, and the arrival of new affordable technological solutions in the market, digital healthcare will eventually become a fundamental business imperative. The challenge to healthcare providers for the future, is to adapt and set strategies that leverage new technology while putting patients at the heart of everything they do.
The Next Revolution in Healthcare: Why the New MSSP Revisions Matter Now More...Health Catalyst
Now more than ever, we are entering a period of rapid change catalyzed by the power of data. On December 21, 2018, the Centers for Medicare and Medicaid Services (CMS) issued a final rule for the Medicare Shared Savings Program (MSSP), strengthening the financial incentives for ACOs to drive improved outcomes. The health systems that embrace data to achieve financial success will grow while the rest will struggle to compete. View this webinar for a discussion on how to prepare.
The US healthcare system didn’t develop overnight, rather, it is the culmination of a series of revolutions within wealthy parts of the world. In this webinar, we explore the high points of history that have led us to our current challenges. While care has steadily improved over time, the cost of that care has risen at a much more dramatic rate. CMS created the MSSP to help mitigate the growth of these costs while providing better care for individuals and populations. On a larger scale, the program serves to shift the healthcare industry towards fee-for-value.
Despite general frustration related to legislative involvement, history has proven that regulatory changes precede attitudinal changes and the MSSP (combined with accurate, timely data) may be just the piece of legislation to help make value-based care a reality. By viewing this webinar you will learn:
- How the US healthcare industry reached its current state.
- Why financial imperatives drive cultural change in our economic model.
- Ways that the MSSP can help your organization achieve financial success.
- Ideas for how to utilize data to develop better healthcare delivery systems.
Dr. Will Caldwell is a strong proponent of the use of data analytics to promote good health and save lives. His area of expertise rests in technology-enabled health care delivery models and value-based care platforms. We hope that you will view this webinar and learn from his 17-years of work as a data-informed clinician.
How healthcare providers should navigate Covid-19 - based on insights from 2,...imogenkw
A survey of 2,000 UK consumers shows how healthcare providers should navigate Covid-19 based on the number of customers avoiding healthcare locations due to the Coronavirus and those interested in virtual appointments and service by phone or video.
Industries covered include: doctors clinics, GPs, sexual health clinics, dentists, therapists and counsellor services.
Big Data Provides Opportunities, Challenges and a Better Future in Health and...Cirdan
This presentation was delivered by Ashraf Mina, NSW Pathology at the Pathology Horizons 2017 Conference in Cairns, Australia.
Pathology Horizons 2017 is an annual CPD conference organised by Cirdan on the future of pathology. You can access more information about the event at www.pathologyhorizons.com
The company was founded in 2010 and is headquartered in Lisburn, Northern Ireland and has additional offices in Canada and Australia.
Cirdan is also responsible for organising Pathology Horizons, an annual and open CPD conference on the future of pathology. For more information visit - www.pathologyhorizons.com
LIMS in Modern Molecular Pathology by Dr. Perry MaxwellCirdan
This presentation was delivered by Dr Perry Maxwell, Queen's University Belfast at Pathology Horizons 2017 in Cairns, Australia.
Pathology Horizons is an annual CPD conference organised by Cirdan on the future of pathology. You can access more information on the event at www.pathologyhorizons.com
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...Cirdan
This presentation introduces and discussesthe concept of ‘morphologomics’ that is omics approaches critically reimagined and reappraised from the viewpoint of classic morphology.
It was delivered by Dr. Anthony Gill at the Pathology Horizons 2017 conference in Cairns, Australia.
introduce and discuss the concept of ‘morphologomics’ that is omics approaches critically reimagined and reappraised from the viewpoint of classic morphology.
The Practical Utility of Social Media Platforms in Pathology and Laboratory M...Cirdan
This presentation was delivered by Dr. Felipe Templo Jr. at the Pathology Horizons 2017 conference in Cairns, Australia.
Pathology Horizons is an annual CPD conference organised by Cirdan on the future of pathology. More information on Pathology Horizons can be accessed at www.pathologyhorizons.com
Computer Aided Diagnosis in Pathology: Pros & Cons by Dr. Liron PantanowitzCirdan
This presentation looks at the benefits and problems related to computer aided diagnosis in pathology. It was delivered by Dr. Liron Pantanowitz, University of Pittsburgh, USA at the Pathology Horizons conference in Cairns, Australia.
Pathology Horizons is an annual CPD conference organised by Cirdan on the future of pathology. More information on Pathology Horizons can be accessed at www.pathologyhorizons.com
A Value-Based Approach to Clinical Pathology and InformaticsCirdan
A presentation delivered by Dr. Glenn Edwards, SA Pathology at the Pathology Horizons 2017 conference in Cairns, Australia.
Pathology Horizons is an annual CPD conference organised by Cirdan on the future of pathology. More information on Pathology Horizons can be accessed at www.pathologyhorizons.com
Knowledge management in context: Implications for clinical pathologists by Dr...Cirdan
Presentation by Dr Glenn Edwards at Pathology Horizons 2016 conference in Galway, entitled: "Knowledge management in context: Implications for clinical pathologists."
The impact of international pathology guidance on the management of patients ...Cirdan
Presentation by Tim Helliwell at Pathology Horizons 2016 conference in Galway, entitled: " The impact of international pathology guidance on the management of patients with cancer."
Spectral analysis for tumour diagnosis and classification in surgical patholo...Cirdan
Presentation by Fabio Grizzi at Pathology Horizons 2016 conference in Galway, entitled: "Spectral analysis for tumour diagnosis and classification in surgical pathology: what is missing?
Detection and Analysis of Long Non-Coding RNAs (IncRNAs) in Anopheles funestu...Cirdan
Presentation by Luke Vanstone at Pathology Horizons 2016 conference in Galway, entitled: "Detection and Analysis of Non-Coding RNAs (IncRNAs) in Anopheles funestus".
Anthony Gill on Lessons learnt for pathologists from the International Cancer...Cirdan
Dr Gill heads in the Cancer Diagnosis and Pathology Research Group at the University of Sydney and is the anatomical pathologist for the Australian Pancreatic Genome Initiative (APGI), part of the International Cancer Genome Consortium (ICGC) effort to sequence human cancers. In this presentation at the Cirdan Pathology Horizons conference 2015, he presents the key results, the challenges and failures of this project and what it will mean in routine clinical care.
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesCirdan
The appropriate ordering project uses data extracted from Electronic Medical Record to create dashboards to inform and engage clinicians in ordering practices. This presentation looks at the techniques used to create answers for the clinicians questions and discusses the purpose behind 12 dashboards. It looks at the change management approaches and challenges.
The initial pilot project has been embraced by a number of local health districts in NSW and templates have been made available along with training tools.
Damian Fogarty on Pathology in the era of connected health: Linking patients,...Cirdan
Damian Fogarty is a Consultant Kidney Physician in the Regional Nephrology and Transplant Unit, Belfast Health and Social Care Trust. From 2010-14 was Chairman of the UK Renal Registry, an internationally recognised national audit body with many innovations and plaudits for its work. Damian has a particular interest in using routine data for quality improvement, better engagement with patient groups and the use of social media in all these areas. In this presentation at the Pathology Horizons 2015 conference of Cirdan,he discusses data analytics for pathology.
Malcolm Pradhan on Pathology in Clincial Decision Support and the role of Dee...Cirdan
Pathology testing plays an important role in the management of complex patients. Pathology laboratories continue to improve the speed and accuracy of result reporting, however the clinical management of pathology remains challenging: there is well documented variation in ordering practices, slow take-up of order sets, and up to 40% of pathology tests are not reviewed by clinical staff. The inefficient clinical utilization of pathology is a significant cost, both directly and through increased patient length of stay in hospital.
One of the established ways to improve health care delivery is integrated clinical decision support (CDS). Malcolm discusses how the effective implementation of CDS for pathology results can improve clinical productivity and patient safety. Looking further ahead the challenge for health care is to develop models of care that better tailor decisions to the needs of individual patients, and technology is required to achieve this goal. He gives a high level overview of recent advances in technology, such as big data analytics and deep learning, that will be vital in creating a sustainable health care system.
Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...Cirdan
Automated image analysis has had a long history but continues to grow with massive improvements in algorithms, speed, performance, and with emerging opportunities for high throughput tissue biomarker analysis and automated decision support for primary diagnostics. Of particular importance is the development of computer vision and image analysis for H&E stained samples. This talk will outline recent advances in automated tissue analysis for biomarker discovery and diagnostics and how adoption of digital pathology will drive the demand for quantitative imaging and decision support.
As an example, PathXL have developed TissueMark for the automated identification and analysis of tumour in lung, colon, breast and prostate cancer digital H&E slides. The conventional pathological estimation of % tumour nuclei in H&E samples shows gross variation between pathologists, undermining the quality of next generation sequencing, molecular testing and patient therapy and potential of false negative diagnoses. TissueMark uses a combination of pattern recognition, glandular analysis and nuclear segmentation to identify premaligant and invasive cancer patterns in H&E stained tissues and use this to assess tumour cell numbers and annotate samples for nucleic acid extraction and molecular profiling. Benchmark data was generated to validate TissueMark technology and showed concordance of automated data with manual counts, accelerating tumour markup and improving sample quality assessment. This represents an example of how automated imaging of tissue samples can be of immense value in quantitative tumour analysis for molecular diagnostics, thereby improving reliability in discovery and diagnostics.
This together with other examples in pathology research and practice will demonstrate that next generation tissue imaging technology in digital pathology could radically change how pathology is practiced.
David Snead on The use of digital pathology in the primary diagnosis of histo...Cirdan
Recent developments in digital pathology enable the rapid scanning of microscope slides at high resolution, making the digitisation of histopathology slides for routine diagnosis purposes feasible. An important initial step in the wider adoption of this technology is the establishment of validation data assessing how effective pathologists are using digital workstations in comparison to conventional light microscopes and glass slides when examining cases for primary diagnosis. I will report on the first study sufficiently powered to demonstrate a statistically valid equivalent (i.e. non-inferior) performance of digital pathology (DP) against standard glass slide (GS) microscopy. This study examined a total of 3,017 cases were included, generating 10,138 slides, which when scanned resulted in a digital archive of 2.45 terabytes. As well as demonstrating non-inferiority of digital in comparison to glass slides the study was useful in establishing rules for slide scanning and identifying areas where digital pathology has limitations and needs to be used with caution.
Finally the presentation covers the impact adopting digital pathology will have on diagnostic laboratories, the economics of these changes and where these changes are most likely to benefit patients.
Christine Swarbrick discusses a pathology imaging system from a user perspectiveCirdan
For 18 months, the Cellular Pathology Laboratory in Craigavon Area Hospital, Northern Ireland, has been getting use to a Pathology Imaging System. This short talk looks at the journey so far and what may lie in the future for a DGH Cell Path Laboratory using such technology systems.
Manuel Salto-Tellez on Personalised medicine and the future of tissue pathologyCirdan
Personalised / Precision Medicine has revolutionized cancer treatment and, in parallel, is also deeply transforming the way we practice tissue pathology. The aim of this talk is to briefly review the status of molecular diagnostic tests applicable to tissues and cells, as well as the main technical and conceptual areas that, in my opinion, will be dictating the evolution of tissue pathology and its integration with the molecular era. These areas are, among others – a) digital pathology in the pipeline of therapeutic pathology; b) tissue-based NGS and its integration in routine diagnostics; c) the promise of liquid biopsy diagnostics and its necessary “partnership” with tissue molecular testing; d) Pathology IT, databases and bioinformatics; and e) the training of future tissue pathologists. In the process of this review, it may be apparent that a solid, integrated, morpho-molecular approach to pathology may serve our patients better.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. Who are Kainos Evolve?
2
Mobile Enabled
Healthcare
Platform
50,000 Users
1 Billion
Documents
80+ Hospitals
10 Million
Patient
Records
70% of UK
NHS EMR
Market
3. Making healthcare delivery easier
through technology
The Evolve Mobile-Enabled
Healthcare platform solves a range
of healthcare delivery challenges
and is being used today across
hundreds of hospitals by thousands
of clinicians to support the care of
millions of patients.
Kainos Evolve
3
8. • VirtMed : The “Tipping Point” has arrived
• VirtMed : Disrupting health care delivery by
lowering costs, improving outcomes, and
promoting greater access and consumer
convenience
• VirtMed : A consumer engagement, care
management and cost containment solution
that as a part of the health care delivery fabric
is creating new health care delivery models for
the first time in decades.
Virtual Medicine (VirtMed)
8
9. • VirtMed will grow from a $250 million US market today to over
$20 billion during the next decade with the potential to top $50
billion when Population Health applications of the technology are
realized.
• VirtMed can:
• Generate cost savings to the health care system of over 95% relative to unnecessary
ER visits, 75% on hospital ambulatory visits and even 25% on low acuity retail clinic
visits.
• Replace almost two-thirds of unnecessary ER visits, generating savings of over $40
billion annually.
• Replace one-third of all ambulatory physician visits at a cost savings of almost $20
billion.
• Function as the remote patient monitoring system under emerging PopHealth
delivery models, generating over $20 billion in annual revenue.
Healthcare 2.0
9Source : RBC VirtMed Report, July 2015
11. 4 fundamental reasons for VirtMed
11
• Consumer
convenience
• Clinical
outcome
benefits
• Making care widely
accessible for
everyone
• Cost benefits
of care at the
point of need
ECONOMICS ACCESS
CONVENIENCEOUTCOMES
12. The drive towards virtual / remote care
12
Estimated Care Distribution 2015 Estimated Care Distribution 2020
Source : Gartner Symposium October 2015
13. How do we transition at light speed to
VirtMed?
13
1. We need a bi-modal healthcare
IT delivery model
2. We need to be able to rapidly
re-engineer and innovate new
care processes with efficient
mobile capture
3. We need access to joined-up,
comprehensive patient data
4. We need all stakeholders in care
provision to collaborate
14. WE NEED A BIMODAL
HEALTHCARE IT DELIVERY MODEL
15. BiModal healthcare technology stack
15
Wearables
Stakeholder
access
Telemedicine
Mobility
Virtual med
EPR
EDM
EHR PACS
PORTAL PATH/RAD
MODE 1 :
Record
MODE 2 :
Engagement
16. WE NEED TO BE ABLE TO
RAPIDLY RE-ENGINEER
AND INNOVATE
NEW CARE PROCESSES
WITH EFFICIENT
MOBILE CAPTURE
18. Virtual medicine in practice
18
I had to show him
where it hurt and
how flexible my
foot was
- Lindsay, Boston
70% of U.S. patients are
comfortable communicating
with doctors via txt, email,
video
19. 19
By 2020, 60% of all
business processes will be
optimised for mobile
Source : Gartner Symposium October 2015
21. 21
The world is being re-invented.
100% of industry processes
will be reimagined.
In an API Economy,
pipeline of data
are reassembled
through Cloud Services.
- Marc Dupaquier
General Manager,
Global Business Partners, IBM
October 2015
22. WE NEED ALL STAKEHOLDERS
IN CARE PROVISION TO
COLLABORATE
27. Case study 1: Elderly Care
27
• Monitored by remote clinician
• Trend analysis
• Intervention alerting
• Targetted programs for heart
failure, heart disease, COPD and
gestational diabetes
Home measurements
• 26% fewer ER visits
• 28% reduction hospital days
• 88% patient satisfaction
• More than 85,000 virtual
visits every month
• Average age : 79
Virtual visits
• 70% of patients said that their
quality of life has improved
• Savings of 30% to 60% in travel
time and costs
28. • 600 wards across 46
hospitals
• 5 million+ sets of
observations taken per
month
• Capture of observations,
alerting to deterioration,
workflowing for
interventions
Case Study 2: Vital Signs Measurement
28
• 15% mortality rate drop
• 750 deaths per year across 2
hospitals
• 10% length of stay reduction
• 70% reduction cardiac arrest
rates
• 50% reduction unplanned ITU
transfers
• 90% reduction Norovirus
outbreaks
29. • Connected vs monolothic
• Separate Pathology systems connected using HL7 / FIHR etc
• Desktop vs mobility
• Mobile interfaces for point-of-care access and capture of
Pathology information
• Everyone active vs pass-the-parcel
• Pathology part of the wider team
• Better communication between parties = faster response,
less wasted resource
• Need flexible workflow and orchestration
Summary : VirtMed for Pathology is now
29
Technology changes slow
National programme UK slowed everything down
Traditional EPR-style systems slow to innovate and hard to get changes out of
Rapidly changing population demographics
Lots of healthcare innovation spending
Changing healthcare consumer landscape – switched on, more educated on rights and medical conditions
Changing regulatory requirements for treatment, information governance
How do you do the above with traditional, siloed sources of information, often on paper with physical information management practices???
This is doctors. As the shortfall continues, the pressure then moves “downstream” to nursing staff etc to plug those work task gaps, exacerbating the pressure across the health care system.
Shortages of in-hospital and GP staff lead to pressure on Emergency Departments, the most expensive care delivery model.
TOP BOX IS HOW MUCH VIRTUAL MEDICINE WILL ESSENTIALLY COST, THE MARKET OPPORTUNITY FOR SUPPLIERS
BOTTOM BOX IS HOW MUCH VIRTUAL MEDICINE WILL SAVE THE HEALTHCARE ECONOMY IN COSTS
The information needs to be stored in systems that can talk to each other.
Not good enough to have Pathology / Radiology as its own island, requiring a separate login and user experience friction.
HOW THE INFORMATION IS ACCESSED AND ADDED TO INCREASINGLY IMPORTANT, ACROSS ALL STAKEHOLDERS
Not good enough to have “hard coded” inflexible systems. Requirements changing too rapidly.
Toolset must allow for incremental changes, agile working practices.
Desk-bound working is no longer acceptable in most scenarios, even a clinic setting. Soft-skills around sitting beside the patient etc.
NATURE
Moving from rigid, specific algorithms (PROCEDURES) to systems being able to present findings in a more intelligent way and spot trends (COGNITIVE), through to the system being able to actively suggest and manage treatment strategies (AUTOMATED)
CLINICIAN LOCATION
Moving from physically with the patient, through to occaisional connected (e.g. telephone), to remote clinics through to not involved at all because the healthcare management system is able to manage the healthcare.
PATIENT LOCATION
From always having to come to hospital to occaisional clinic visits (e.g. clinic hubs for remote treatment in rural areas) to telehealth in home through to wherever they are via virtual medicine.
FOR PATHOLOGY : increasing intelligence to help support reporting and decision making. Less unnecessary requests.
Consumers increasingly capable with remote working.
Rise of Skype, email, instant messaging.
Rise of apps that are helping manage long-term conditions, monitoring and tracking via manual input or wearables.
High level of the other 40% will also be performed on mobile, just not necessarily specifically optimised for it.
Need all the information to be accessed in one place.
Not necessarily in the one system, but all systems must talk together.
National Programme in UK now more about standards and interoperability.
Pathology systems need to be able to talk with the common interfaces. FIHR will help this greatly, as it simplifies the integration process.
Everything moving towards a connected way of working.
If you don’t have an API, automatically relegated to “silo” status.
Freedom for the information consumer to use the data in a way that makes most sense to them.
The solutions that will ultimately win are the ones who can communicate, but also have compelling, useful, interfaces that make the best use of their own and everyone else’s data.
Virtual Medicine only works when we actually do work as a team.
Patients constantly frustrated at level of non-collaboration and information flow between their care teams.
Too many cases of things falling between the cracks.
The healthcare organisations that will ultimately succeed are the ones who can orchestrate and manage the patient care from initial visit, diagnosis, treatment, follow-up through to discharge, which will involve several teams and organisations.
Record and careplan central to it all, but must be appropriately shared to all to ensure care quality and safety.
Given physician shortage, ER visits are going up rapidly – UK a prime example.
Shortage of GPs causes the same effect.
Communications networks, infrastructure now in place.
Social acceptance of online communications growing.
Main blocker is politics between organisations (and central government lack of momentum)